Trial Profile
A Phase II Study of Weekly Genexol-PM in Patients With Advanced Hepatocelluar Carcinoma After Failure of Sorafenib
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 02 Feb 2021 Status changed from recruiting to discontinued (Due to poor accrual).
- 06 Jan 2017 New trial record